Press release
Global HIV Drugs Market Analysis of Emerging Key Vendors Such as Gilead Sciences, ViiV Healthcare, Janssen, Merck & Co., Bristol-Myers Squibb, TaiMed Biologics, CytoDyn, Boehringer Ingelheim International GmbH, AbbVie and many more.
Request for Sample Pages: https://www.insightaceanalytic.com/report-details/global-hiv-drugs-market-assessment/
According to the latest research by InsightAce
Analytic, the global HIV drugs market was valued at US$ XX Mn in 2020 and it is expected to reach US$ XX million in 2028, at a promising CAGR of XX% from 2020 to 2028.
Acquired immunodeficiency syndrome (AIDS) is caused by the human immunodeficiency virus (HIV). The virus damages the immune system and thus interferes with the body's ability to fight organisms that cause disease. HIV attacks immune cells specifically CD-4 cells and makes the body susceptible to infections and other diseases.
AIDS is a life-threatening and chronic disease that can be transmitted from one person to another through various routes including sexual intercourse, direct injection with HIV-contaminated drugs, needles, syringes, blood or blood products, and from HIV-infected mother to fetus. As of now, no cure for AIDS, however antiretroviral regimens (ARVs) are recommended for patients with HIV as it can dramatically slow the disease progression as well as prevent other infections and complications.
Increasing the prevalence of HIV/AIDS across the world catalyzing the growth of the global HIV drugs market. According to UNAIDS, in 2019, the total number of patients with HIV/AIDS was around 38 million across the globe. The adult and children population was 36.2 and 1.8 million respectively.
Additionally, several initiatives undertaken by governments/associations/organizations in respective countries and globally to educate and raise awareness, availability of generic HIV drugs, and new drug development and regulatory approvals for HIV treatment are expected to further drive the market. For instance, in March 2020, ViiV Healthcare, the subsidiary of GlaxoSmithKline received regulatory approval for its long-acting, regimen for the treatment of HIV; CABENUVA by Health Canada.
Request for ToC/Proposal: https://www.insightaceanalytic.com/report-details/global-hiv-drugs-market-assessment/
The HIV drugs market is fragmented with the presence of many players that operates in the local as well as international markets.
Global HIV drugs market report covers major players such as Gilead Sciences, ViiV Healthcare, Janssen, Merck & Co., Bristol-Myers Squibb, TaiMed Biologics, CytoDyn, Boehringer Ingelheim International GmbH, AbbVie, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Cipla Limited, Daiichi Sankyo, Emcure, Hetero Drugs, and Mylan among others.
Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/report-details/global-hiv-drugs-market-assessment/
Market Segments
Global HIV Drugs Market Revenue (US$ Mn), by Product, 2018-2028
o Zolgensma
o Atripla
o Biktarvy
o Complera
o Delstrigo
o Descovy
o Dovato
o Genvoya
o Isentress
o Juluca
o Odefsey
o Stribild
o Symtuza
o Tivicay
o Triumeq
o Trogarzo
o Truvada
o Cabotegravir/Rilpivirine
o Fostemsavir
o Leronlimab
o Others
Global HIV Drugs Market Revenue (US$ Mn), By Region, 2018-2028
North America HIV Drugs Market Revenue (US$ Mn), by Country, 2020-2028
o U.S.
o Canada
Europe HIV Drugs Market Revenue (US$ Mn), by Country, 2020-2028
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
o Rest of Europe
Asia Pacific HIV Drugs Market Revenue (US$ Mn), by Country, 2020-2028
Latin America HIV Drugs Market Revenue (US$ Mn), by Country, 2020-2028
Middle East & Africa HIV Drugs Market Revenue (US$ Mn), by Country, 2020-2028
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global HIV Drugs market
To receive industry overview and future trends HIV Drugs market
To analyze the HIV Drugs market drivers and challenges
To get information on HIV Drugs market size value/revenue (US$ Mn) forecast till 2028
Major Investments, Mergers & Acquisition in HIV Drugs industry
For More Information @https://www.insightaceanalytic.com/report-details/global-hiv-drugs-market-assessment/
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global HIV Drugs Market Analysis of Emerging Key Vendors Such as Gilead Sciences, ViiV Healthcare, Janssen, Merck & Co., Bristol-Myers Squibb, TaiMed Biologics, CytoDyn, Boehringer Ingelheim International GmbH, AbbVie and many more. here
News-ID: 2181799 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd.
Organic Feminine Care Market to Benefit from Increasing Government Initiatives a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Organic Feminine Care Market Size, Share & Trends Analysis Report By Product Type (Sanitary Pads, Tampons, Menstrual Cups, Liners and Shields, Others), by Nature (Disposable, Reusable), by Age Group (Upto 18 Years, 19-30 Years, 31-40 Years, 41 Years and Above), by Distribution Channel (Supermarkets and hypermarkets, Pharmacy, Online Stores, Others)- Market Outlook And Industry Analysis…
Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2031"
The global Intravenous Immunoglobulin market is estimated to reach over USD 21.22 billion by 2031, exhibiting a CAGR of 6.60% during the forecast period.
Get Free Access…
Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Compa …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Exascale Computing Market - (By Component (Hardware, Software, Services), By Deployment (On-premises, Cloud-based), By Customer Type (Government & Defense, Healthcare & Biosciences, Financial Services, Research & Academia, Manufacturing & Energy, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Exascale Computing Market is valued at…
Plasma Fractionation Market Robust Expansion is expected to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Plasma Fractionation Market- (By Product (Immune-Globulins(Intravenous Immune-Globulins, Subcutaneous Immune-Globulins, Other Immune-Globulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Others), Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes)),…
More Releases for HIV
HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792
This latest report researches the industry structure, sales, revenue,…
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
